123 related articles for article (PubMed ID: 15882193)
1. Disruption of the interactions between the subunits of herpesvirus DNA polymerases as a novel antiviral strategy.
Loregian A; Palù G
Clin Microbiol Infect; 2005 Jun; 11(6):437-46. PubMed ID: 15882193
[TBL] [Abstract][Full Text] [Related]
2. Identification of a small molecule that inhibits herpes simplex virus DNA Polymerase subunit interactions and viral replication.
Pilger BD; Cui C; Coen DM
Chem Biol; 2004 May; 11(5):647-54. PubMed ID: 15157875
[TBL] [Abstract][Full Text] [Related]
3. Protein-protein interactions as targets for antiviral chemotherapy.
Loregian A; Marsden HS; Palù G
Rev Med Virol; 2002; 12(4):239-62. PubMed ID: 12125015
[TBL] [Abstract][Full Text] [Related]
4. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
[TBL] [Abstract][Full Text] [Related]
5. 2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases.
Schnute ME; Anderson DJ; Brideau RJ; Ciske FL; Collier SA; Cudahy MM; Eggen M; Genin MJ; Hopkins TA; Judge TM; Kim EJ; Knechtel ML; Nair SK; Nieman JA; Oien NL; Scott A; Tanis SP; Vaillancourt VA; Wathen MW; Wieber JL
Bioorg Med Chem Lett; 2007 Jun; 17(12):3349-53. PubMed ID: 17434304
[TBL] [Abstract][Full Text] [Related]
6. Interactions between virus and antiviral compounds in the host cell.
Harmenberg J
Med Biol; 1984; 62(6):299-303. PubMed ID: 6099858
[No Abstract] [Full Text] [Related]
7. Selective anti-cytomegalovirus compounds discovered by screening for inhibitors of subunit interactions of the viral polymerase.
Loregian A; Coen DM
Chem Biol; 2006 Feb; 13(2):191-200. PubMed ID: 16492567
[TBL] [Abstract][Full Text] [Related]
8. Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.
Real E; Rain JC; Battaglia V; Jallet C; Perrin P; Tordo N; Chrisment P; D'Alayer J; Legrain P; Jacob Y
J Virol; 2004 Jul; 78(14):7410-7. PubMed ID: 15220414
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of herpesvirus and influenza virus replication by blocking polymerase subunit interactions.
Palù G; Loregian A
Antiviral Res; 2013 Sep; 99(3):318-27. PubMed ID: 23748148
[TBL] [Abstract][Full Text] [Related]
10. Non-nucleosidic inhibition of Herpes simplex virus DNA polymerase: mechanistic insights into the anti-herpetic mode of action of herbal drug withaferin A.
Grover A; Agrawal V; Shandilya A; Bisaria VS; Sundar D
BMC Bioinformatics; 2011; 12 Suppl 13(Suppl 13):S22. PubMed ID: 22373101
[TBL] [Abstract][Full Text] [Related]
11. Peptide-mediated interference with influenza A virus polymerase.
Ghanem A; Mayer D; Chase G; Tegge W; Frank R; Kochs G; García-Sastre A; Schwemmle M
J Virol; 2007 Jul; 81(14):7801-4. PubMed ID: 17494067
[TBL] [Abstract][Full Text] [Related]
12. Non-nucleoside inhibitors of herpesviruses.
Wathen MW
Rev Med Virol; 2002; 12(3):167-78. PubMed ID: 11987142
[TBL] [Abstract][Full Text] [Related]
13. Herpesvirus DNA polymerases: Structures, functions and inhibitors.
Zarrouk K; Piret J; Boivin G
Virus Res; 2017 Apr; 234():177-192. PubMed ID: 28153606
[TBL] [Abstract][Full Text] [Related]
14. An importin alpha/beta-recognized bipartite nuclear localization signal mediates targeting of the human herpes simplex virus type 1 DNA polymerase catalytic subunit pUL30 to the nucleus.
Alvisi G; Musiani D; Jans DA; Ripalti A
Biochemistry; 2007 Aug; 46(32):9155-63. PubMed ID: 17640102
[TBL] [Abstract][Full Text] [Related]
15. The structure and function of the HSV DNA replication proteins: defining novel antiviral targets.
Matthews JT; Terry BJ; Field AK
Antiviral Res; 1993 Feb; 20(2):89-114. PubMed ID: 8384825
[TBL] [Abstract][Full Text] [Related]
16. Human cytomegalovirus DNA replication: antiviral targets and drugs.
Mercorelli B; Sinigalia E; Loregian A; Palù G
Rev Med Virol; 2008; 18(3):177-210. PubMed ID: 18027349
[TBL] [Abstract][Full Text] [Related]
17. Prediction of activity, synthesis and biological testing of anti-HSV active peptides.
Jenssen H; Gutteberg TJ; Rekdal Ø; Lejon T
Chem Biol Drug Des; 2006 Jul; 68(1):58-66. PubMed ID: 16923027
[TBL] [Abstract][Full Text] [Related]
18. Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet.
Bonnafous P; Naesens L; Petrella S; Gautheret-Dejean A; Boutolleau D; Sougakoff W; Agut H
Antivir Ther; 2007; 12(6):877-88. PubMed ID: 17926642
[TBL] [Abstract][Full Text] [Related]
19. Human herpesvirus 6 DNA polymerase: enzymatic parameters, sensitivity to ganciclovir and determination of the role of the A961V mutation in HHV-6 ganciclovir resistance.
De Bolle L; Manichanh C; Agut H; De Clercq E; Naesens L
Antiviral Res; 2004 Oct; 64(1):17-25. PubMed ID: 15451175
[TBL] [Abstract][Full Text] [Related]
20. Novel inhibitors of human CMV.
Andrei G; De Clercq E; Snoeck R
Curr Opin Investig Drugs; 2008 Feb; 9(2):132-45. PubMed ID: 18246516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]